Search
Search Results
##search.searchResults.foundPlural##
-
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4118PDF: 1943HTML: 1764 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6081PDF: 3243HTML: 9018Figure Malaria Ricci: 227 -
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
1878PDF: 939Html: 319 -
Does splenectomy influence the development of Hypothyroidism in Transfusion Dependent Thalassemia Patients? A retrospective study. Splenectomy in Hypothyroidism of TDT patients
1216PDF: 937HTML: 307 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1376HTML: 395PDF: 820 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4245PDF: 1517HTML: 447 -
-
How I treat acute and persistent sickle cell pain
1927PDF: 1117HTML: 485 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3687PDF: 1236HTML: 3889Untitled: 212Untitled: 259 -
AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA
1982PDF: 896HTML: 1865 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2556PDF: 964HTML: 15105 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1614PDF: 990HTML: 358 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3173PDF: 1151HTML: 394 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6955PDF: 3920HTML: 24881 -
ASSESSMENT OF DIAGNOSTIC TECHNIQUES OF URINARY TUBERCULOSIS
2008PDF: 779HTML: 2325Untitled: 210 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2193PDF: 797HTML: 1627Figure 1: 182Table 1: 205 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4318PDF: 1490HTML: 1547Untitled: 225 -
Spontaneous rupture of malarial spleen: report of two cases
805PDF: 407HTML: 2869jdoe, cover letter.doc: 177 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2412PDF: 923HTML: 529 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1298PDF: 1009HTML: 122 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
976PDF: 361HTML: 196 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2185PDF: 1168HTML: 2588Study of serum haptoglobin level in thalassemia: 343Figures: 176







